Parkinson's disease: Investigational drug may reduce involuntary movements
Tuesday, April 12, 2011 - 16:30
in Health & Medicine
Results of the first randomized, placebo-controlled long-term clinical trial show the investigational drug safinamide may reduce dyskinesia or involuntary movements in mid-to-late stage Parkinson's disease.